Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Sees Large Increase in Short Interest

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a large increase in short interest in November. As of November 15th, there was short interest totalling 14,400 shares, an increase of 585.7% from the October 31st total of 2,100 shares. Based on an average daily volume of 14,300 shares, the short-interest ratio is currently 1.0 days.

Reviva Pharmaceuticals Trading Down 6.5 %

Shares of NASDAQ:RVPHW traded down $0.01 during trading on Friday, hitting $0.22. The stock had a trading volume of 2,615 shares, compared to its average volume of 16,128. The stock has a 50-day simple moving average of $0.14 and a two-hundred day simple moving average of $0.18. Reviva Pharmaceuticals has a 12-month low of $0.07 and a 12-month high of $1.62.

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.